Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Simply Wall StNov 24 07:17 ET

Stephens Initiates Fennec Pharmaceuticals(FENC.US) With Buy Rating, Announces Target Price $15

Moomoo NewsNov 19 03:36 ET · Ratings

Express News | Fennec Pharmaceuticals Inc : Stephens Initiates Coverage With Overweight Rating; Target Price $15

ReutersNov 19 01:28 ET

Fennec Pharmaceuticals to Participate in Upcoming Investor Conference

GlobeNewswireNov 13 06:27 ET

Fennec Pharmaceuticals Inc: INTERIM MDA EN

SEDARNov 12 18:47 ET · Announcements

Fennec Pharmaceuticals Inc: INTERIM FINANCIAL STATEMENTSREPORT EN

SEDARNov 12 18:46 ET · Announcements